GlassScriptPhysician profile
Jacob Blair
NPI 1356918312
$1,344.78
in general payments reported to CMS, 2019-2025
12 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $69.98 · 2023: $240 · 2024: $671 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $448.29 | 2021-2024 | Clareon, Centurion, Rocklatan |
| Amgen INC. | $236.69 | 2024-2025 | Tepezza |
| Abbvie INC. | $222.73 | 2023-2024 | Ozurdex |
| Apellis Pharmaceuticals, INC. | $124.46 | 2024 | Syfovre |
| Mallinckrodt Hospital Products INC. | $119.81 | 2024 | Acthar |
| Horizon Therapeutics Plc | $81.42 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $28.13 | 2024 | |
| Novo Nordisk INC | $22.31 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.90 | 2024 | Purified Cortrophin Gel |
| Glaukos Corporation | $16.66 | 2022 | |
| Lifescan, INC. | $13.47 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.